Literature DB >> 12814917

No clinical evidence for CD4+ cell depletion caused by rituximab.

M Wayne Saville, Mark C Benyunes, Pratik S Multani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12814917     DOI： 10.1182/blood-2003-03-1005

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Preventing autoimmunity protects against the development of hypertension and renal injury.

Authors:  Keisa W Mathis; Kedra Wallace; Elizabeth R Flynn; Christine Maric-Bilkan; Babbette LaMarca; Michael J Ryan
Journal:  Hypertension       Date:  2014-07-14       Impact factor: 10.190

Review 2.  [Therapy of follicular lymphoma].

Authors:  C Buske; M Unterhalt; W Hiddeman
Journal:  Internist (Berl)       Date:  2007-04       Impact factor: 0.743

3.  Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Nancy L Monson; Petra Cravens; Rehana Hussain; Christopher T Harp; Matthew Cummings; Maria de Pilar Martin; Li-Hong Ben; Julie Do; Jeri-Anne Lyons; Amy Lovette-Racke; Anne H Cross; Michael K Racke; Olaf Stüve; Mark Shlomchik; Todd N Eagar
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.